Clinical Trial Update: AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the immunogenicity and safety of three doses of a lipopeptide vaccine for HIV prevention, compared with placebo, in HIV-uninfected volun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Lipopeptide vaccine candidate (lipopeptide vaccine)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED